Company Description
XWELL, Inc. engages in the provision of health and wellness services to travelers in the United States and internationally.
It operates in three segments: XpresSpa, XpresTest, and Naples Wax Center. The XpresSpa segment provides traveler’s spa services, including massage, and nail and skin care services, as well as spa and travel products.
The XpresTest segment offers COVID-19 and other medical testing to the traveling public, as well as airline, airport and concessionaire employees, and TSA and U.S. customs and border protection agents; aircraft wastewater and passenger nasal sampling through the CDC’s bio-surveillance program; and various services and support, including technical support services and advanced services.
The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services.
It offers its services through stores and kiosks, as well as online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022.
XWELL, Inc. is based in New York, New York.
| Country | United States |
| Founded | 2006 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 280 |
| CEO | Ezra Ernst |
Contact Details
Address: 254 West 31st Street, 11th Floor New York, New York 10001 United States | |
| Phone | 212 750 9595 |
| Website | xwell.com |
Stock Details
| Ticker Symbol | XWEL |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001410428 |
| CUSIP Number | 98420U802 |
| ISIN Number | US98420U8027 |
| SIC Code | 7200 |
Key Executives
| Name | Position |
|---|---|
| Ezra T. Ernst | President and Chief Executive Officer |
| Thomas Ian Brown | Chief Financial Officer |
| Patti Ward | Chief Operating Officer |
| Mike Heronime | Marketing Director |
| Peter Vermeulen | Head of Human Resources |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 21, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Oct 20, 2026 | 8-K | Current Report |
| Oct 8, 2026 | DEF 14A | Other definitive proxy statements |
| Oct 8, 2026 | 8-K | Current Report |
| Sep 8, 2026 | SCHEDULE 13D/A | Filing |
| Aug 14, 2026 | 10-Q | Quarterly Report |
| Aug 13, 2026 | SCHEDULE 13G/A | Filing |
| Aug 12, 2026 | SCHEDULE 13G/A | Filing |
| Aug 5, 2026 | 8-K | Current Report |
| Aug 4, 2026 | SCHEDULE 13D | Filing |